Home/Filings/4/0001801170-24-000068
4//SEC Filing

Loengard Anna U 4

Accession 0001801170-24-000068

CIK 0001801170other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 4:30 PM ET

Size

8.3 KB

Accession

0001801170-24-000068

Insider Transaction Report

Form 4
Period: 2024-03-14
Transactions
  • Purchase

    Class A Common Stock

    2024-03-14$0.73/sh+137,000$100,010538,841 total
  • Purchase

    Class A Common Stock

    2024-03-14$0.73/sh+13,625$9,94615,125 total(indirect: By Daughter in a Custodial Account)
Holdings
  • Class A Common Stock

    (indirect: By Spouse)
    10,000
  • Class A Common Stock

    (indirect: By Son in a Custodial Account)
    1,300
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average purchase price. These shares were purchased on the Transfer Date in multiple transactions at prices ranging from $0.73 to $0.74 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Issuer

CLOVER HEALTH INVESTMENTS, CORP. /DE

CIK 0001801170

Entity typeother

Related Parties

1
  • filerCIK 0001952723

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:30 PM ET
Size
8.3 KB